https://www.selleckchem.com/pr....oducts/bromelain.htm
BACKGROUND The antioxidant properties of epigallocatechin-gallate (EGCG), a green tea compound, have been already studied in various diseases. Improving the bioavailability of EGCG by nanoformulation may contribute to a more effective treatment of diabetes mellitus (DM) metabolic consequences and vascular complications. The aim of this study was to test the comparative effect of liposomal EGCG with EGCG solution in experimental DM induced by streptozotocin (STZ) in rats. METHOD 28 Wistar-Bratislava rats were randomly divided into four
Beğen
Yorum Yap
Paylaş
